English name | Lurasidone Hydrochloride 盐酸鲁拉西酮 |
Synonyms | Lurasidonhydrochloride;Lurasidonhydrochlorid;(3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dionehydrochloride;(3aR,4S,7R,7aS)-2-(((1R,2R)-2-((4-(benzo[d]isothiaChemicalbookzol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dionehydrochloride;LurasidoneHydrochlorideTablets;ExodieneLurasidone;LurasidoneHCl/LurasidoneHydrochloride;(3aR,4R,7S,7aS)-2-(((1R,2R)-2-((4-(benzo[d]isothiazol-3-yl) |
CAS | 367514-88-3 |
EINECS | 682-423-6 |
Molecular formula | C28H37ClN4O2S |
Molecular weight | 529.14 |
Chemical formula | |
Melting point | 198-205°C |
Flashing point | 9℃ |
Solubility | DMSO : 10 mg/mL (18.90 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble) |
Storage condition | Refrigerator |
Appearance | Powder |
InChIKey | PQXKDMSYBGKCJA-CVTJIBDQSA-N |
Use | Lurasidone hydrochloride is an organic synthesis intermediate and pharmaceutical intermediate, which can be used in laboratory research and development of organic synthesis process and chemical pharmaceutical synthesis process. |
Package | （According to user requirements） |
Dangerous mark | F,T |
Risk phrases | 11-23/24/25-39/23/24/25 |
Safety phrases | 7-16-36/37-45 |
Dangerous goods transport No. | UN1230 - class 3 - PG 2 - Methanol, solution |
Upstream raw materials | Ar (3, 4 s, 7 r, 7 as) 4, 7 - methylene - 1 h - different indole - 1, 3 (2 h) - diketone (3 ar, 7 ar) - 4 '- (1, 2 - benzo vary thiazole -- 3 -) eight hydrogen screw (2) indole - 2 h, 1' - piperazine] mesilate |
